A retrospective cohort study assessing the safety and efficacy of oral anticoagulants in the treatment of acute venous thromboembolism as compare to vitamin K antagonists in France
Latest Information Update: 14 Jan 2022
At a glance
- Drugs Apixaban (Primary) ; Rivaroxaban (Primary) ; Vitamin K antagonists
- Indications Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 04 Jan 2022 Results published in the Thrombosis and Haemostasis
- 26 Nov 2021 New trial record